23andMe Research

A team of scientists at 23andMe created a new model to better estimate skin cancer risk, one of the most commonly diagnosed forms of cancer. Details of the new model...

In July, 23andMe launched a large-scale study of idiopathic pulmonary fibrosis (IPF), a serious disease that scars the lungs for reasons that scientists have yet to understand.23andMe currently has more...

By Eli Chanoff, 23andMe Research AssociateParkinson’s disease (PD) has been a central focus of 23andMe’s research since our company’s early years. Over more than a decade, we have grown a...

Even with promising COVID-19 vaccines on the horizon, it will likely be many months before they are widely available. This means that we must continue to do what we can...

Research shows that there really are “cat people” and “dog people.” Being one or the other is associated with differences in personality and well-being, according to new data analyzed by...

23andMe recently launched a genetic study of systemic sclerosis, a rare autoimmune disease that results in the hardening and thickening of the skin and other organs, for which there is...

Like almost everything this year, the annual meeting of the American Society of Human Genetics will be virtual.Instead of having thousands of scientists converge on a city for a week...

Studying the impact of direct-to-consumer genetic testing on consumers, 23andMe scientists found that people who received information about genetic risk for a certain type of blood clots, found it useful, and in some cases, took actions to lower their risk.

Getting a grip on the genetics of left-handedness, a new study uncovers dozens of genes involved giving researchers new insight into the structure of the brain.

New data from 23andMe shows that although people became less active early in the COVID-19 pandemic, activity-levels measured in steps have gone back up.